Viewing Study NCT05111561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-27 @ 8:55 PM
Study NCT ID: NCT05111561
Status: SUSPENDED
Last Update Posted: 2025-11-19
First Post: 2021-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Metastatic Malignant Solid Neoplasm View
None Refractory Malignant Solid Neoplasm View
None Triple-Negative Breast Carcinoma View
None Unresectable Malignant Solid Neoplasm View
Keywords: